BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25485561)

  • 1. Renal replacement therapy with regional citrate anticoagulation as an effective method to treat hypercalcemic crisis.
    Gradwohl-Matis I; Franzen M; Seelmaier C; Brunauer A; Dankl D; Dünser MW; Salmhofer H
    ASAIO J; 2015; 61(2):219-23. PubMed ID: 25485561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate.
    Gupta M; Wadhwa NK; Bukovsky R
    Am J Kidney Dis; 2004 Jan; 43(1):67-73. PubMed ID: 14712429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia.
    Srámek V; Novák I; Matĕjovic M; Rokyta R; Nalos M; Hora P; Pittrová H
    Intensive Care Med; 1998 Mar; 24(3):262-4. PubMed ID: 9565811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation.
    Kindgen-Milles D; Kram R; Kleinekofort W; Morgera S
    ASAIO J; 2008; 54(4):442-4. PubMed ID: 18645366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.
    Cointault O; Kamar N; Bories P; Lavayssiere L; Angles O; Rostaing L; Genestal M; Durand D
    Nephrol Dial Transplant; 2004 Jan; 19(1):171-8. PubMed ID: 14671053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction.
    De Vico P; Messino V; Tartaglione A; Beccaris C; Buonomo C; Talarico D; Prati P; Sabato AF; Colella DF
    Ther Apher Dial; 2015 Jun; 19(3):272-8. PubMed ID: 25656632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury.
    Durão MS; Monte JC; Batista MC; Oliveira M; Iizuka IJ; Santos BF; Pereira VG; Cendoroglo M; Santos OF
    Crit Care Med; 2008 Nov; 36(11):3024-9. PubMed ID: 18824904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A; Ross EA
    Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation.
    Meier-Kriesche HU; Finkel KW; Gitomer JJ; DuBose TD
    Am J Kidney Dis; 1999 Apr; 33(4):e8. PubMed ID: 10196039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional citrate anticoagulation in continuous venovenous hemodiafiltration.
    Kutsogiannis DJ; Mayers I; Chin WD; Gibney RT
    Am J Kidney Dis; 2000 May; 35(5):802-11. PubMed ID: 10793012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
    Morgera S; Haase M; Ruckert M; Krieg H; Kastrup M; Krausch D; Vargas-Hein O; Zuckermann-Becker H; Peters H; Pohlmeier R; Neumayer HH
    Nephron Clin Pract; 2005; 101(4):c211-9. PubMed ID: 16155399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge.
    Gabutti L; Marone C; Colucci G; Duchini F; Schönholzer C
    Intensive Care Med; 2002 Oct; 28(10):1419-25. PubMed ID: 12373466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
    Khadzhynov D; Schelter C; Lieker I; Mika A; Staeck O; Neumayer HH; Peters H; Slowinski T
    J Crit Care; 2014 Apr; 29(2):265-71. PubMed ID: 24360392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
    Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration--a comparison between 2 citrate modalities and unfractionated heparin.
    Balik M; Zakharchenko M; Leden P; Otahal M; Hruby J; Polak F; Rusinova K; Stach Z; Tokarik M; Vavrova J; Jabor A; Oudemans-van Straaten HM
    J Crit Care; 2013 Feb; 28(1):87-95. PubMed ID: 22951019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulation for continuous renal replacement therapy in the intensive care unit: a comparison of dalteparin infusion with regional citrate anticoagulation].
    Uljas E; Karjalainen M; Vaara S; Reinikainen M
    Duodecim; 2015; 131(11):1079-84. PubMed ID: 26245070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.